Goldman Sachs’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-79,526
| Closed | -$115K | – | 5009 |
|
|
2024
Q1 | $115K | Hold |
79,526
| – | – | ﹤0.01% | 4440 |
|
|
2023
Q4 | $5.96K | Hold |
79,526
| – | – | ﹤0.01% | 4681 |
|
|
2023
Q3 | $11.9K | Hold |
79,526
| – | – | ﹤0.01% | 4601 |
|
|
2023
Q2 | $7.16K | Hold |
79,526
| – | – | ﹤0.01% | 4819 |
|
|
2023
Q1 | $4.37K | Hold |
79,526
| – | – | ﹤0.01% | 5020 |
|
|
2022
Q4 | $3.63K | Hold |
79,526
| – | – | ﹤0.01% | 5025 |
|
|
2022
Q3 | $4K | Buy |
79,526
+142
| +0.2% | +$7 | ﹤0.01% | 5344 |
|
|
2022
Q2 | $12K | Hold |
79,384
| – | – | ﹤0.01% | 5495 |
|
|
2022
Q1 | $22K | Hold |
79,384
| – | – | ﹤0.01% | 5595 |
|
|
2021
Q4 | $40K | Hold |
79,384
| – | – | ﹤0.01% | 5390 |
|
|
2021
Q3 | $46K | Hold |
79,384
| – | – | ﹤0.01% | 5205 |
|
|
2021
Q2 | $79K | Buy |
+79,384
| New | +$79K | ﹤0.01% | 5173 |
|